UGC approved journals list

The list of journals approved by UGC, University Grant Commission, New Delhi

Journals no. on UGC are provided here for researchers quick reference.

Sr. No. Journal No. Journal Name Link
3440 49349 Chemical Biology Letters
6337 47927 Journal of Materials NanoScience
6512 49358 Journal of Biomedical and Therapeutic Sciences
4703 47906 Integrated Research Advances
44231 44231 Advanced Organic Chemistry Letters

6496 Journal of Integrated Science and Technology

Chemical Biology Letters

Journal of Materials NanoScience

Journal of Biomedical and Therapeutic Sciences

Integrated Research Advances

Advanced Organic Chemistry Letters

Inhibitory effects of reserpine against efflux pump activity of antibiotic resistance bacteria

By Sridevi Dhanarani, Shankar Congeevaram, Prakash Piruthiviraj, Joon Hong Park, Thamaraiselvi Kaliannan Antibiotic resistant bacteria (ABR) is an alarming issue and it has to be eliminated before enter into the environment. The role of efflux pump inhibitor, reserpine – a plant alkaloid in reducing the antibiotic resistance in Staphylococcus sp., Streptococcus sp. and Micrococcus sp. from poultry litter were evaluated. Reserpine increased the activity of antibiotics against bacteria and directly blocks the antibiotic efflux pump. Resistances of bacteria to antibiotics were reduced when they were grown in the presence of reserpine. Furthermore, this compound effectively reduced the Minimum Inhibitory Concentration (MIC) of several antibiotics such as ampicillin, erythromycin, tetracycline, chloramphenicol, streptomycin, kanamycin, rifampicin and tobramycin, suggesting that reserpine are representatives of bacterial efflux inhibitors with the potential application in combination therapy for veterinary medicines. This defensive action will helps us to reduce the existence of ABR in poultry industry as well as in the environment.



Nuclear Medicine – recent advances in radiopharmaceuticals – special issue

Special Issue on Nuclear Medicine
Journal Name: Chemical Biology Letters
Editor(s): Dr. Anil K. Mishra, Scientist G

Nuclear Medicine, a medical specialty involving the application of radioactive substances in the diagnosis and treatment of disease have been highly successful in diagnosis of difficult to detect diseases and therapy of various dreaded diseases. Recently, there have been a tremendous research progress in development of newer methods, conjugates and pharmaceuticals for diagnosis and therapy using radioactive materials.

The purpose of this special issue proposal is to summarize the recent advances in the field of new potential molecular targets/mechanism of actions, new radioconjugates development, clinical evaluation and application of new radiopharmaceuticals, and new techniques/therapy development. Recent progress will be covered through research articles, review articles and short communications.

The subtopics to be covered in this issue are (though not limited to):

– Chemistry of new radioactive elements.
– Organic chemistry of radiopharmaceuticals, chelating agents and standalone radiopharmaceuticals.
– Progress in SPECT.
– Progress in Positron Emission Tomography (PET).
– Application of nanoscience and nanotechnology to Nuclear Medicine.
– Identification of new therapeutic targets.
– Treatment advances of various diseases – cancer, infections, inflammations etc using radiopharmaceuticals.
– Clinical studies and evaluation of radiopharmaceuticals.
– Malarial/mycobacterial/microbial/viral diagnosis and therapy including biochemical aspects.
– Therapeutic and diagnostic applications.
– New therapeutic policies and emerging targets for Nuclear Medicine.
– New approaches adopted for the development of new radiodiagnostic and radiotherapeutic molecules.
– Rational design and drug discovery-Structure-activity relationship (SAR).
– Synthetic strategies of new radioactive conjugate molecules.
– Molecular self-assembly as drug delivery carriers of radiopharmaceuticals – Nanotechnology and Biotechnology.
– Environmental aspects, safety measures advances in nuclear medicine.

Provisional Schedule:

Final manuscripts due: Dec 15, 2017


Dr. Anil Mishra
Dr. Anil Kumar Mishra
Scientist ‘G’
Add Director, Institute of Nuclear Medicine and Allied Science,
DRDO, Timarpur, Delhi. India

Nuclear Medicine researchers are invited to submit their research / review article for this special issue. Manuscript should be prepared and submitted as per author guidelines provided on journal site.

Important Links:

Author Guidelines for preparation of manuscript:

Manuscript template (download): Download template MS word 2007-2010, Citation manager style files and other details are provided in author guidelines section on journal site.

Manuscript Submission:

Chemical Biology Letters Chemical Biology Letters Chemical Biology Letters